Manufacturer
538 recalls in our database name Aidapak Services, LLC as the manufacturing or recalling firm.
Of the 538 recalls from Aidapak Services, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 127 (24%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Aidapak Services, LLC is recalling 40 mg atorvastatin calcium tablets that may have been mislabeled as 10 mg atorvastatin or 5 mg finasteride.
Aidapak Services is recalling Fluvastatin 20 mg capsules because they may have been mislabeled as a different medication.
Aidapak Services, LLC is recalling Gabapentin 600 mg tablets because they may have been mislabeled as Aripiprazole 15 mg.
Aidapak Services, LLC is recalling Ascorbic Acid chew tablets because they may have been mislabeled as Phenol lozenges.
Aidapak Services, LLC is recalling Vitamin B Complex tablets because they may have been mislabeled as other drugs. The repacked products were distributed in four western states.
Aidapak Services, LLC is recalling 2 mg Nicotine Polacrilex Gum due to a potential labeling mixup with Folic Acid or Quetiapine Fumarate tablets.
Aidapak Services, LLC is recalling CapsuleTOPRIL 25 mg tablets because they may have been mislabeled as Duloxetine HCl DR 20 mg capsules.
Aidapak Services is recalling Calcium Acetate tablets that may be mislabeled as Ascorbic Acid or Hyoscyamine Sulfate.
Aidapak Services, LLC is recalling specific lots of multivitamin chew tablets because they may have been mislabeled as other drugs.
Aidapak Services, LLC is recalling Bumetanide 1 mg tablets that may have been mislabeled as Guaifenesin ER 600 mg. The error could lead to incorrect medication administration.
Aidapak Services, LLC is recalling Atropine Sulfate/Diphenoxylate HCL tablets because they may have been mislabeled as Cyanocobalamin or Tri-Buffered Aspirin.
Aidapak Services, LLC is recalling Modafinil 200 mg tablets because they may have been mislabeled as Omega-3-Acid Ethyl Esters capsules.
Aidapak Services, LLC is recalling CapsuleTOPRIL 6.25 mg tablets because they may have been mislabeled as Lubiprostone 24 mcg capsules.
Aidapak Services, LLC is recalling 500 mg Mycophenolate Mofetil tablets because they may be mislabeled as 250 mg capsules.
Aidapak Services is recalling Paricalcitol capsules because they may have been mislabeled as Ascorbic Acid or Cholecalciferol.
Aidapak Services, LLC is recalling Dicyclomine HCL 20 mg tablets because they may have been mislabeled as Ramipril 2.5 mg capsules.
Aidapak Services, LLC is recalling Bumetanide 0.5 mg tablets because they may have been mislabeled as Erythromycin DR EC 250 mg.
Aidapak Services is recalling Valsartan 320 mg tablets because they may have been mislabeled as Cilostazol 100 mg.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Omega-3 Acid Ethyl Esters capsules due to a potential label mixup with other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 403 tablets of Pyridoxine HCL 50 mg because they may have been mislabeled as other medications. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Aidapak Services is recalling 20 mg Pantoprazole Sodium DR tablets because they may be mislabeled as Hyoscyamine Sulfate or Multivitamin/Multimineral.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets due to a potential label mixup with Magnesium Chloride. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Bromocriptine Mesylate 2.5 mg tablets because they may have been mislabeled as Cyanocobalamin 1000 mcg.
Aidapak Services is recalling Valsartan 160 mg tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.